Monotherapy with mastic does not eredicate Helicobacter pylori infection from mice

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 367-371

  Loughlin, Michael F ^a   Ala'Aldeen, Dlawer A ^a   Jenks, Peter J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Eradication; Helicobacter pylori; Mastic; Mouse model

Indexed keywords

AMPHOTERICIN B; BACITRACIN; CLARITHROMYCIN; MASTIC; METRONIDAZOLE; NALIDIXIC ACID; OMEPRAZOLE; PLANT EXTRACT; POLYMYXIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIULCER AGENT; PLANT RESIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VITRO STUDY; INOCULATION; LIQUID CULTURE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MOUSE; NONHUMAN; PISTACHIO; TREATMENT FAILURE; ANIMAL; BACTERIAL COUNT; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STOMACH;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; METRONIDAZOLE; MICE; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; RESINS, PLANT; STOMACH;

EID: 0037323737     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg057     Document Type: Article

References (24)

1. Warren, J. R. (1983). Unidentified curved bacilli on gastric epithelium in chronic active gastritis. Lancet i, 1273.
2. Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P., Jones, R., Axon, A. et al. (2002). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 consensus report. Alimentary Pharmacology and Therapeutics 16, 167-80.
3. Huwez, F. U. & Al-Habbal, M. J. (1986). Mastic in treatment of benign gastric ulcers. Gastroenterologia Japonica 21, 273-4.
4. Al-Habbal, M. J., Al-Habbal, Z. & Hubez, F. U. (1984). A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clinical and Experimental Pharmacology and Physiology 11, 541-4.
5. Al-Said, M. S., Ageel, A. M., Parmar, N. S. & Tariq, M. (1986). Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. Journal of Ethnopharmacology 15, 271-8.
6. Huwez, F. U., Thirlwell, D., Cockayne, A. & Ala'Aldeen, D. A. (1998). Mastic gum kills Helicobacter pylori. New England Journal of Medicine 339, 1946.
7. Magiatis, P., Melliou, E., Skaltsounis, A. L., Chinou, I. B. & Mitaku, S. (1999). Chemical composition and antimicrobial activity of the essential oils of Pistacia lenticus var. chia. Planta Medica 65, 749-52.
8. Jenks, P. J., Labigne, A. & Ferrero, R. L. (1999). Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrobial Agents and Chemotherapy 43, 777-81.
9. Jenks, P. J., Ferrero, R. L. & Labigne, A. (1999). The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori. Journal of Antimicrobial Chemotherapy 43, 753-8.
10. Jenks, P. J., Ferrero, R. L., Tankovic, J., Thiberge, J. M. & Labigne, A. (2000). Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice. Antimicrobial Agents and Chemotherapy 44, 2623-9.
11. Lee, A., O'Rourke, J., De Ungria, M. C., Robertson, B., Daskalopoulos, G. & Dixon, M. F. (1997). A standardized mouse model of Helicobacter pylori infection: introducing the Sydney Strain. Gastroenterology 112, 1386-97.
12. Coudron, P. E. & Stratton, C. W. (1998). In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori. Journal of Antimicrobial Chemotherapy 42, 657-60.
13. Liu, W. Z., Xiao, S. D., Shi, Y., Wu, S. M., Zhang, D. Z., Xu, W. W. et al. (1999). Furazolidone-containing short-term therapies are effective in the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 13, 317-22.
14. Mégraud, F., Occhialini, A. & Rossignol, J. F. (1998). Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole. Antimicrobial Agents and Chemotherapy 42, 2836-40.
15. Jonkers, D., van den Broek, E., van Dooren, I., Thijs, C., Dorant, E., Hageman, G. et al. (1999). Antibacterial effect of garlic and omeprazole on Helicobacter pylori. Journal of Antimicrobial Chemotherapy 43, 837-9.
16. O'Gara, E. A., Hill, D. J. & Maslin, D. J. (2000). Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Applied and Environmental Microbiology 66, 2269-73.
17. Mabe, K., Yamada, M., Oguni, I. & Takahashi, T. (1999). In vitro and in vivo activity of tea catechins against Helicobacter pylori. Antimicrobial Agents and Chemotherapy 43, 1788-91.
18. Yee, Y. K. & Koo, M. W. (2000). Anti-Helicobacter pylori activity of Chinese tea: in vitro study. Alimentary Pharmacology and Therapeutics 14, 615-8.
19. Marone, P., Bono, L., Leone, E., Bona, S., Carretto, E. & Perversi, L. (2001). Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. Journal of Chemotherapy 13, 611-4.
20. Tassou, C. C. & Nychas, G. J. (1995). Antimicrobial activity of the essential oil of mastic gum (Pistacia lentiscus var. chia) on Gram positive and Gram negative bacteria in broth and in model food system. International Biodeterioration and Biodegradation 36, 411-20.
21. Dick-Hegedus, E. & Lee, A. (1991). Use of a mouse model to examine anti-Helicobacter pylori agents. Scandinavian Journal of Gastroenterology 26, 909-15.
22. Sizemore, C. F., Quispe, J. D., Amsler, K. M., Modzelewski, T. C., Merrill, J. J., Stevenson, D. A. et al. (2002). Effects of metronidazole, tetracycline and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model. Antimicrobial Agents and Chemotherapy 46, 1435-40.
23. Goodwin, C. S. (1997). Antimicrobial treatment of Helicobacter pylori infection. Clinical Infectious Diseases 25, 1023-6.
24. Graham, D. Y., Saeed, M. A., Hoffman, J., El-Zimaity, H. M., Kwon, D. H. & Osato, M. S. (2001). Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Alimentary Pharmacology and Therapeutics 15, 513-8.